AIM1

AIM1

A gene on chromosome 6q21 that encodes a protein thought to suppress melanoma, possibly by interacting with the cytoskeleton.
References in periodicals archive ?
Aim1: I intend to develop methods to expand adult stem cells from the human lung.
Abscisic acid induced MYB transcription factor (AIM1) was not expressed in non-treated tomato plants, and it had strong expression with NaCl and AgNP treatment combinations with the exception of NaCl200 AgNPs2 treatment, which had the lowest expression level and the level was similar to the non-treated plants.
However, AIM1 expression increased by 2.71-fold after exposure to AgNPs under NaCl150.
Of the investigated salt stress genes in tomato plants, the AIM1, AGP-S1, APX2, LOX1 and MAPK2 genes were expressed only under NaCl stress, and they were not expressed in non-treated plants.
Esos substanciosos gastos militares han representado siempre jugosos negocios para la industria armamentista norteamericana, que ha suministrado tambien muchos miles de millones de dolares en armas a Israel, entre otras rifles M-16, misiles aire-aire AIM1 20C-5, canones Gatling para cazas F-1 6 y helicopteros de ataque Apache.
The Aurora-B is encoded by the AURKB gene (also known as AIK2; AIM1; ARK2; AurB; IPL1; STK5; AIM1; STK12), mapped to chromosome 17p13.1, and consisting of 9 exons (Gene ID: 9212).
In this context, Our research will be divided in two steps: Delineating the role of lipids on gpcr conformational landscape at the molecular scale (aim1) and exploring an additional allosteric factor in line with lipid composition, The homo- and hetero-receptor oligomerisation (aim2).
This project will uncover the spatiotemporal dynamics of hfscs fate decisions and establish the role of the niche in this process (aim1), Decipher key gene-regulatory networks and epigenetic barriers that control phenotypic plasticity (aim2), And discover druggable signaling networks that drive bi-directional reprogramming of hfscs and their progeny (aim3).
This will enable production of clinical grade retargeted-HSVs for clinical tests (AIM1) Engineer retargeted-HSVs suitable for systemic delivery and for boosting anti-tumor immunity (AIM2-3) Apply our platform to expand the repertoire of oncolytic HSVs that target glioblastomas, prostate, head-and-neck, colon carcinomas (AIM4) Determine the tumorigenic potential of cancer cells that escape killing by retargeted HSVs (AIM5)